Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Centessa Pharmaceuticals plc - American Depositary Shares
(NQ:
CNTA
)
39.72
+12.14 (+44.02%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
47,746,221
Open
40.03
Bid (Size)
39.56 (100)
Ask (Size)
39.70 (200)
Prev. Close
27.58
Today's Range
39.57 - 40.26
52wk Range
9.600 - 40.26
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
March 31, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why Centessa Stock Soared Today
↗
March 31, 2026
A pharma giant wants to buy the innovative drug developer.
Via
The Motley Fool
Performance
YTD
+67.7%
+67.7%
1 Month
+49.8%
+49.8%
3 Month
+60.5%
+60.5%
6 Month
+63.8%
+63.8%
1 Year
+176.2%
+176.2%
More News
Read More
Halper Sadeh LLC is Investigating Whether APLS, CNTA, BIRD, WBD are Obtaining Fair Deals for their Shareholders
March 31, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
March 31, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Tuesday?
↗
March 31, 2026
Via
Chartmill
The market is filled with gapping stocks in Tuesday's session.
↗
March 31, 2026
Via
Chartmill
The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
March 31, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Intellectual Property
The $1 Trillion Goliath: Why Eli Lilly’s $6.3B Centessa Bet Defines the Future of Neuroscience
March 31, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Discover the top movers in Tuesday's pre-market session.
↗
March 31, 2026
Via
Chartmill
CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders
March 31, 2026
From
Halper Sadeh LLC
Via
Business Wire
Forget Centessa Pharmaceuticals: This Rare‑Disease Specialist Has a Superior Portfolio and Pipeline
↗
February 26, 2026
Via
The Motley Fool
Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50%
↗
February 23, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition
↗
February 19, 2026
Via
The Motley Fool
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
February 03, 2026
From
Centessa Pharmaceuticals plc
Via
GlobeNewswire
This Fund Locked In Gains With a $14.5 Million Biotech Exit Amid a Staggering Stock Rally
↗
February 01, 2026
Via
The Motley Fool
Topics
ETFs
Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
January 14, 2026
From
Centessa Pharmaceuticals plc
Via
GlobeNewswire
This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits
↗
December 29, 2025
Via
The Motley Fool
Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications
December 11, 2025
From
Centessa Pharmaceuticals plc
Via
GlobeNewswire
What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company
↗
November 29, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity?
↗
November 18, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out
↗
November 18, 2025
Via
The Motley Fool
This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying
↗
November 17, 2025
Via
The Motley Fool
Topics
Regulatory Compliance
This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover
↗
November 17, 2025
Via
The Motley Fool
Frequently Asked Questions
Is Centessa Pharmaceuticals plc - American Depositary Shares publicly traded?
Yes, Centessa Pharmaceuticals plc - American Depositary Shares is publicly traded.
What exchange does Centessa Pharmaceuticals plc - American Depositary Shares trade on?
Centessa Pharmaceuticals plc - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares?
The ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares is CNTA on the Nasdaq Stock Market
What is the current price of Centessa Pharmaceuticals plc - American Depositary Shares?
The current price of Centessa Pharmaceuticals plc - American Depositary Shares is 39.72
When was Centessa Pharmaceuticals plc - American Depositary Shares last traded?
The last trade of Centessa Pharmaceuticals plc - American Depositary Shares was at 03/31/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.